凝血酶激活的纤溶抑制物通路改变与重型血友病A出血表型相关
结果显示患者纤溶抑制物通路受损,且TAFIa生成与反应随出血倾向加重而降低,严重出血者循环TAFIa/ai最高,提示该通路可用于出血风险分层。
要点
- 重型血友病A患者存在TAFI通路受损,表现为纤溶时间缩短和TAFIa生成减少。
- TAFIa生成及对TAFIa的反应随出血倾向加重而下降。
- TAFI相关指标明显低于中位数者出血率和因子消耗高3至4倍。
核心结论
- TAFI通路受损与重型血友病的出血表型相关,可能有助于出血风险分层。
主要发现
- 与对照相比,血友病患者血块溶解时间更短、TAFIa生成更少、对TAFIa的反应降低,但TAFIa/ai水平相似。
- 轻、中、重度出血者的血块溶解时间相似,而TAFIa生成和对TAFIa的反应随出血倾向增加而下降。
- 循环TAFIa/ai水平在重度出血者中最高。
- TAFIa生成或反应明显受损(低于中位数)的患者出血率和因子消耗比TAFI相关值接近对照的患者高3至4倍。
临床怎么用
- 对于重型血友病A患者,可考虑检测TAFI相关指标以辅助评估出血风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with severe hemophilia A display varied bleeding phenotypes despite similar factor VIII (FVIII) activity levels. OBJECTIVE: We investigated different thrombin activatable fibrinolysis inhibitor (TAFI)-related variables in patients with severe hemophilia A and their possible correlation with bleeding tendency. PATIENTS/METHODS: Sixty-one patients with severe hemophilia A (FVIII:C <1%], treated on demand, were included. Patients were categorized as mild, moderate, and severe bleeders according to number of bleeds per year (≤2, 3-24, ≥25, respectively). Thirty healthy males served as controls. Clot lysis time was assessed by turbidimetric assay, TAFI activation by two-stage functional assay, and response to TAFIa as the prolongation of fibrinolysis time upon addition of purified TAFIa. Circulating levels of activated TAFI (TAFIa/ai) were measured by specific enzyme-linked immunosorbent assay. RESULTS: As compared to controls, hemophilic patients displayed shorter lysis time, less TAFIa generation, and reduced response to TAFIa, but similar TAFIa/ai levels. Clot lysis time was similar in mild, moderate, and severe bleeders, whereas TAFIa generation and response to TAFIa decreased with the increase in bleeding tendency; moreover, circulating TAFIa/ai levels were highest in severe bleeders. Patients with markedly impaired TAFIa generation or TAFIa response (below median) displayed 3-fold to 4-fold higher bleeding rate and factor consumption than patients whose TAFI-related values approached the control ones. CONCLUSION: The TAFI pathway impairment correlates with bleeding phenotype in severe hemophilia and may represent a promising tool to stratify the bleeding risk.
引用
- Semeraro F, Mancuso ME, Ammollo CT, et al. Thrombin activatable fibrinolysis inhibitor pathway alterations correlate with bleeding phenotype in patients with severe hemophilia A. J Thromb Haemost. 2019. PMID: 31571361. doi:10.1111/jth.14656
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。